Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The earlier notice Revision: v3.4.1 and related government funding/operating status notices were removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and a new revision tag (v3.4.1) were added, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:18:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and metadata updates include showing the glossary and adding the QC-related label 'Last Update Submitted that Met QC Criteria' and the revision tag 'Revision: v3.4.0'. The earlier QC label, 'No FEAR Act data,' and 'Revision: v3.3.4' text are removed or updated accordingly.
    Difference
    0.2%
    Check dated 2026-01-28T04:56:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:20.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added new study locations: Greater Manchester, Hampshire, Kent, and West Midlands, with the page revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T09:22:35.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Minor wording update in the Publications section: 'These publications are provided voluntarily by the person who enters information about the study and are about the results of the study' was changed to improve grammar (Revision: v3.2.0 → v3.3.2); to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:52:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.